{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T04:21:30Z","timestamp":1769314890143,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-025-01130-w","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T16:35:09Z","timestamp":1758213309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["One-step Immobilization of Human \u03b1-1-acid Glycoprotein on Magnetic Beads: A Rapid Method for Small Molecule hAGP Binding Study"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1186-6669","authenticated-orcid":false,"given":"Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5839-4765","authenticated-orcid":false,"given":"Hamid","family":"Samareh Afsari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7282-5795","authenticated-orcid":false,"given":"Steven","family":"Anderlot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6737-0928","authenticated-orcid":false,"given":"Aaron M.","family":"Teitelbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0300-726X","authenticated-orcid":false,"given":"Mitchell E.","family":"Taub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"1130_CR1","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1002\/jps.23614","volume":"102","author":"T Bohnert","year":"2013","unstructured":"Bohnert T, Gan L. Plasma protein binding: From discovery to development. J Pharm Sci. 2013;102:2953\u201394.","journal-title":"J Pharm Sci"},{"key":"1130_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1517\/17460441.2.1.51","volume":"2","author":"GL Trainor","year":"2007","unstructured":"Trainor GL. The importance of plasma protein binding in drug discovery. Expert Opin Drug Discov. 2007;2:51\u201364.","journal-title":"Expert Opin Drug Discov"},{"key":"1130_CR3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/nrd3287","volume":"9","author":"DA Smith","year":"2010","unstructured":"Smith DA, Di L, Kerns EH. The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat Rev Drug Discov. 2010;9:929\u201339.","journal-title":"Nat Rev Drug Discov"},{"key":"1130_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11095-022-03172-7","volume":"39","author":"SG Summerfield","year":"2022","unstructured":"Summerfield SG, Yates JWT, Fairman DA. Free Drug Theory \u2013 No Longer Just a Hypothesis? Pharm Res. 2022;39:213\u201322.","journal-title":"Pharm Res"},{"key":"1130_CR5","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2174\/1381612821666150302113710","volume":"21","author":"Z Zhivkova","year":"2015","unstructured":"Zhivkova Z. Studies on Drug \u2013 Human Serum Albumin Binding: The Current State of the Matter. Curr Pharm Des. 2015;21:1817\u201330.","journal-title":"Curr Pharm Des"},{"key":"1130_CR6","doi-asserted-by":"publisher","first-page":"e02879","DOI":"10.1016\/j.heliyon.2019.e02879","volume":"5","author":"M Bteich","year":"2019","unstructured":"Bteich M. An overview of albumin and alpha-1-acid glycoprotein main characteristics: highlighting the roles of amino acids in binding kinetics and molecular interactions. Heliyon. 2019;5:e02879.","journal-title":"Heliyon"},{"key":"1130_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0167-4838(00)00153-9","volume":"1482","author":"T Fournier","year":"2000","unstructured":"Fournier T, Medjoubi-N N, Porquet D. Alpha-1-acid glycoprotein. Biochimica Et Biophysica Acta Bba - Protein Struct Mol Enzym. 2000;1482:157\u201371.","journal-title":"Biochimica Et Biophysica Acta Bba - Protein Struct Mol Enzym"},{"key":"1130_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1081\/DMR-100104402","volume":"33","author":"ZH Israili","year":"2001","unstructured":"Israili ZH, Dayton PG. Human Alpha-1-glycoprotein and its Interactions with Drugs\u2020,\u2021. Drug Metab Rev. 2001;33:161\u2013235.","journal-title":"Drug Metab Rev"},{"key":"1130_CR9","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1158\/1078-0432.CCR-11-2684","volume":"18","author":"J Wu","year":"2012","unstructured":"Wu J, LoRusso PM, Matherly LH, Li J. Implications of Plasma Protein Binding for Pharmacokinetics and Pharmacodynamics of the \u03b3-Secretase Inhibitor RO4929097. Clin Cancer Res. 2012;18:2066\u201379.","journal-title":"Clin Cancer Res"},{"key":"1130_CR10","doi-asserted-by":"crossref","unstructured":"Mackiewicz A, Kushner I, Baumann H, Eap CB, Baumann P. Acute Phase Proteins. 2020;107\u201316.","DOI":"10.1201\/9781003068587"},{"key":"1130_CR11","doi-asserted-by":"publisher","first-page":"462240","DOI":"10.1016\/j.chroma.2021.462240","volume":"1649","author":"SR Beeram","year":"2021","unstructured":"Beeram SR, Zhang C, Suh K, Clarke WA, Hage DS. Characterization of drug binding with alpha1-acid glycoprotein in clinical samples using ultrafast affinity extraction. J Chromatogr A. 2021;1649:462240.","journal-title":"J Chromatogr A"},{"key":"1130_CR12","doi-asserted-by":"publisher","first-page":"121834","DOI":"10.1016\/j.saa.2022.121834","volume":"285","author":"S-L Jiang","year":"2023","unstructured":"Jiang S-L, Li L, Hu L, Kou S-B, Shi J-H. Comprehending binding features between ibrutinib and Human Alpha-1 acid glycoprotein: Combined experimental approaches and theoretical simulations. Spectrochim Acta Part A: Mol Biomol Spectrosc. 2023;285:121834.","journal-title":"Spectrochim Acta Part A: Mol Biomol Spectrosc"},{"key":"1130_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bbrc.2023.02.021","volume":"651","author":"D Dimitrijevic","year":"2023","unstructured":"Dimitrijevic D, Fabian E, Funk-Weyer D, Landsiedel R. Rapid equilibrium dialysis, ultrafiltration or ultracentrifugation? Evaluation of methods to quantify the unbound fraction of substances in plasma. Biochem Biophys Res Commun. 2023;651:114\u201320.","journal-title":"Biochem Biophys Res Commun"},{"key":"1130_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.chroma.2017.08.073","volume":"1519","author":"C Bi","year":"2017","unstructured":"Bi C, Matsuda R, Zhang C, Isingizwe Z, Clarke W, Hage DS. Studies of drug interactions with alpha1-acid glycoprotein by using on-line immunoextraction and high-performance affinity chromatography. J Chromatogr A. 2017;1519:64\u201373.","journal-title":"J Chromatogr A"},{"key":"1130_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijbiomac.2020.01.077","volume":"147","author":"M Mic","year":"2020","unstructured":"Mic M, P\u00eern\u0103u A, Floare CG, Bogdan M. Study of the binding affinity between imatinib and \u03b1-1 glycoprotein using nuclear spin relaxation and isothermal titration calorimetry. Int J Biol Macromol. 2020;147:326\u201332.","journal-title":"Int J Biol Macromol"},{"key":"1130_CR16","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1016\/j.xphs.2023.06.015","volume":"112","author":"C Bae","year":"2023","unstructured":"Bae C, Chung G, Chung S-J. Prediction of the Time to Reach Equilibrium for Improved Estimation of the Unbound Fraction of Compounds in Equilibrium Dialysis Using kinetic Modeling. J Pharm Sci. 2023;112:2901\u20139.","journal-title":"J Pharm Sci"},{"key":"1130_CR17","first-page":"1373","volume":"27","author":"H Kurz","year":"1977","unstructured":"Kurz H, Trunk H, Weitz B. Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration. Arznei-forschung. 1977;27:1373\u201380.","journal-title":"Arznei-forschung"},{"key":"1130_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00216-010-3737-1","volume":"398","author":"K Vuignier","year":"2010","unstructured":"Vuignier K, Schappler J, Veuthey J-L, Carrupt P-A, Martel S. Drug\u2013protein binding: a critical review of analytical tools. Anal Bioanal Chem. 2010;398:53\u201366.","journal-title":"Anal Bioanal Chem"},{"key":"1130_CR19","first-page":"535","volume":"23","author":"DS Morse","year":"1985","unstructured":"Morse DS, Abernethy DR, Greenblatt DJ. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs. Int J Clin Pharmacol, Ther, Toxicol. 1985;23:535\u20139.","journal-title":"Int J Clin Pharmacol, Ther, Toxicol"},{"key":"1130_CR20","doi-asserted-by":"crossref","unstructured":"Wang T, Whitcher-Johnstone A, Keith-Luzzi M, Chan TS. HLM-beads: Rapid assessment of non-specific binding to human liver microsomes using magnetizable beads. Drug Metab Dispos. 2021;49:DMD-AR-2021\u2013000575.","DOI":"10.1124\/dmd.121.000575"},{"key":"1130_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/0005-2795(78)90047-8","volume":"536","author":"C Zentz","year":"1978","unstructured":"Zentz C, Fr\u00e9noy J-P, Bourrillon R. Binding of galactose and lactose to ricin. Equilibrium studies. Biochim Biophys Acta (BBA) - Protein Struct. 1978;536:18\u201326.","journal-title":"Biochim Biophys Acta (BBA) - Protein Struct"},{"key":"1130_CR22","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/0003-2697(83)90406-2","volume":"128","author":"PM Horowitz","year":"1983","unstructured":"Horowitz PM, Barnes LD. A simple, inexpensive, and precise microcell for the exchange dialysis and equilibrium dialysis of small samples. Anal Biochem. 1983;128:478\u201380.","journal-title":"Anal Biochem"},{"key":"1130_CR23","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1002\/jps.21317","volume":"97","author":"NJ Waters","year":"2008","unstructured":"Waters NJ, Jones R, Williams G, Sohal B. Validation of a Rapid Equilibrium Dialysis Approach for the Measurement of Plasma Protein Binding. J Pharm Sci. 2008;97:4586\u201395.","journal-title":"J Pharm Sci"},{"key":"1130_CR24","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1023\/A:1024406221962","volume":"20","author":"K-J Lee","year":"2003","unstructured":"Lee K-J, Mower R, Hollenbeck T, Castelo J, Johnson N, Gordon P, et al. Modulation of Nonspecific Binding in Ultrafiltration Protein Binding Studies. Pharmaceut Res. 2003;20:1015\u201321.","journal-title":"Pharmaceut Res"},{"key":"1130_CR25","doi-asserted-by":"publisher","first-page":"151s","DOI":"10.1111\/j.1472-8206.1990.tb00073.x","volume":"4","author":"B Sebille","year":"1990","unstructured":"Sebille B. Methods of drug protein binding determinations. Fundam Clin Pharmacol. 1990;4:151s-s161.","journal-title":"Fundam Clin Pharmacol"},{"key":"1130_CR26","first-page":"1987","volume":"113","author":"T Wang","year":"2024","unstructured":"Wang T, Whitcher-Johnstone A, Scaringella Y, Keith-Luzzi M, Shao J, Taub ME, et al. Comparison of Commonly Used and New Methods to Determine Small Molecule Non-Specific Binding to Human Liver Microsomes. J Pharm Sci. 2024;113:1987\u201395.","journal-title":"J Pharm Sci"},{"key":"1130_CR27","doi-asserted-by":"publisher","unstructured":"Dere R, Yi JH, Lei C, Saad OM, Huang C, Li Y, Baudys J, Kaur S. PK assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine. Bioanalysis. 2013;5(9):1025\u201340. https:\/\/doi.org\/10.4155\/bio.13.72.","DOI":"10.4155\/bio.13.72"},{"key":"1130_CR28","doi-asserted-by":"crossref","unstructured":"Chen LZ, Roos D, Philip E. Development of immunocapture-LC\/MS assay for dimultaneous ADA isotyping and semiquantitation. J Immunol Res. 2016;2016:7682472.","DOI":"10.1155\/2016\/7682472"},{"key":"1130_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jchromb.2013.02.039","volume":"925","author":"M Tsunehiro","year":"2013","unstructured":"Tsunehiro M, Meki Y, Matsuoka K, Kinoshita-Kikuta E, Kinoshita E, Koike T. A Phos-tag-based magnetic-bead method for rapid and selective separation of phosphorylated biomolecules. J Chromatogr B. 2013;925:86\u201394.","journal-title":"J Chromatogr B"},{"key":"1130_CR30","doi-asserted-by":"publisher","first-page":"e53531","DOI":"10.7554\/eLife.53531","volume":"9","author":"H Vais","year":"2020","unstructured":"Vais H, Wang M, Mallilankaraman K, Payne R, McKennan C, Lock JT, et al. ER-luminal [Ca2+] regulation of InsP3 receptor gating mediated by an ER-luminal peripheral Ca2+-binding protein. eLife. 2020;9:e53531.","journal-title":"eLife"},{"key":"1130_CR31","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1126\/science.abg9175","volume":"372","author":"L Stamatatos","year":"2021","unstructured":"Stamatatos L, Czartoski J, Wan Y-H, Homad LJ, Rubin V, Glantz H, et al. mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection. Science. 2021;372:1413\u20138.","journal-title":"Science"},{"key":"1130_CR32","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","volume":"183","author":"L Piccoli","year":"2020","unstructured":"Piccoli L, Park Y-J, Tortorici MA, Czudnochowski N, Walls AC, Beltramello M, et al. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology. Cell. 2020;183:1024-1042.e21.","journal-title":"Cell"},{"key":"1130_CR33","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.procbio.2023.01.014","volume":"126","author":"AFS Rodrigues","year":"2023","unstructured":"Rodrigues AFS, da Silva AF, da Silva FLB, dos Santos KM, de Oliveira MP, Nobre MMR, et al. A scientometric analysis of research progress and trends in the design of laccase biocatalysts for the decolorization of synthetic dyes. Process Biochem. 2023;126:272\u201391.","journal-title":"Process Biochem"},{"key":"1130_CR34","doi-asserted-by":"crossref","unstructured":"Gama Cavalcante AL, Dari DN, Izaias da Silva Aires F, Carlos de Castro E, Moreira Dos Santos K, Sousa Dos Santos JC. Advancements in enzyme immobilization on magnetic nanomaterials: toward sustainable industrial applications. RSC Adv. 2024;14:17946\u201388.","DOI":"10.1039\/D4RA02939A"},{"key":"1130_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-62703-398-5_1","volume":"1008","author":"MA Williams","year":"2013","unstructured":"Williams MA. Protein-Ligand Interactions, Methods and Applications. Methods Mol Biol. 2013;1008:3\u201334.","journal-title":"Methods Mol Biol"},{"key":"1130_CR36","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1021\/acs.jproteome.8b00309","volume":"17","author":"M Baerenfaenger","year":"2018","unstructured":"Baerenfaenger M, Meyer B. Intact Human Alpha-Acid Glycoprotein Analyzed by ESI-qTOF-MS: Simultaneous Determination of the Glycan Composition of Multiple Glycosylation Sites. J Proteome Res. 2018;17:3693\u2013703.","journal-title":"J Proteome Res"},{"key":"1130_CR37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jmb.2008.09.020","volume":"384","author":"DL Sch\u00f6nfeld","year":"2008","unstructured":"Sch\u00f6nfeld DL, Ravelli RBG, Mueller U, Skerra A. The 1.8-\u00c5 Crystal Structure of \u03b11-Acid Glycoprotein (Orosomucoid) Solved by UV RIP Reveals the Broad Drug-Binding Activity of This Human Plasma Lipocalin. J Mol Biol. 2008;384:393\u2013405.","journal-title":"J Mol Biol"},{"key":"1130_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.aspen.2015.03.006","volume":"18","author":"D Morokuma","year":"2015","unstructured":"Morokuma D, Xu J, Mon H, Hirata K, Hino M, Kuboe S, et al. Human alpha 1-acid glycoprotein as a model protein for glycoanalysis in baculovirus expression vector system. J Asia-Pac \u00c8ntomol. 2015;18:303\u20139.","journal-title":"J Asia-Pac \u00c8ntomol"},{"key":"1130_CR39","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41579-019-0243-0","volume":"17","author":"B Macek","year":"2019","unstructured":"Macek B, Forchhammer K, Hardouin J, Weber-Ban E, Grangeasse C, Mijakovic I. Protein post-translational modifications in bacteria. Nat Rev Microbiol. 2019;17:651\u201364.","journal-title":"Nat Rev Microbiol"},{"key":"1130_CR40","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.xphs.2024.01.018","volume":"113","author":"C Thomas","year":"2024","unstructured":"Thomas C, Byer-Alcorace A, Wang T. Human Serum Albumin Immobilized On Magnetizable Beads: A Rapid Method for Compound HSA Binding Study. J Pharm Sci. 2024;113:1359\u201367.","journal-title":"J Pharm Sci"},{"key":"1130_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4155\/bio-2021-0217","volume":"14","author":"C Kittinger","year":"2021","unstructured":"Kittinger C, Delmar J, Hewitt L, Holcomb R, Jones C, Jones H, et al. Critical reagents for ligand-binding assays: process development methodologies to enable high-quality reagents. Bioanalysis. 2021;14:117\u201335.","journal-title":"Bioanalysis"},{"key":"1130_CR42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/elps.200410070","volume":"26","author":"A Holmberg","year":"2005","unstructured":"Holmberg A, Blomstergren A, Nord O, Lukacs M, Lundeberg J, Uhl\u00e9n M. The biotin-streptavidin interaction can be reversibly broken using water at elevated temperatures. Electrophoresis. 2005;26:501\u201310.","journal-title":"Electrophoresis"},{"key":"1130_CR43","doi-asserted-by":"publisher","first-page":"7996","DOI":"10.1021\/acs.analchem.9b01873","volume":"91","author":"S Bearden","year":"2019","unstructured":"Bearden S, Wang F, Hall AR. Simple and Efficient Room-Temperature Release of Biotinylated Nucleic Acids from Streptavidin and Its Application to Selective Molecular Detection. Anal Chem. 2019;91:7996\u20138001.","journal-title":"Anal Chem"},{"key":"1130_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1021\/acsomega.9b03013","volume":"5","author":"JHT Luong","year":"2020","unstructured":"Luong JHT, Vashist SK. Chemistry of Biotin-Streptavidin and the Growing Concern of an Emerging Biotin Interference in Clinical Immunoassays. ACS Omega. 2020;5:10\u20138.","journal-title":"ACS Omega"},{"key":"1130_CR45","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1021\/acs.bioconjchem.1c00283","volume":"32","author":"U Kratzer","year":"2021","unstructured":"Kratzer U, Sommersdorf C, Maier S, Wagner TR, Templin M, Joos TO, et al. Tris(hydroxymethyl)aminomethane Compatibility with N-Hydroxysuccinimide Ester Chemistry: Biotinylation of Peptides and Proteins in TRIS Buffer. Bioconjugate Chem. 2021;32:1960\u20135.","journal-title":"Bioconjugate Chem"},{"key":"1130_CR46","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1002\/j.1460-2075.1987.tb02503.x","volume":"6","author":"L Dente","year":"1987","unstructured":"Dente L, Pizza MG, Metspalu A, Cortese R. Structure and expression of the genes coding for human alpha 1-acid glycoprotein. EMBO J. 1987;6:2289\u201396.","journal-title":"EMBO J"},{"key":"1130_CR47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1365-2125.1993.tb04224.x","volume":"36","author":"F Herve","year":"1993","unstructured":"Herve F, Gomas E, Duche J, Tillement J. Evidence for differences in the binding of drugs to the two main genetic variants of human alpha 1-acid glycoprotein. Br J Clin Pharmacol. 1993;36:241\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"1130_CR48","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s40268-017-0193-9","volume":"17","author":"K Hanada","year":"2017","unstructured":"Hanada K. Lipophilicity Influences Drug Binding to \u03b11-Acid Glycoprotein F1\/S Variants But Not to the A Variant. Drugs RD. 2017;17:475\u201380.","journal-title":"Drugs RD"}],"updated-by":[{"DOI":"10.1208\/s12248-025-01160-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000}}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01130-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-025-01130-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01130-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T19:02:45Z","timestamp":1762196565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-025-01130-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["1130"],"URL":"https:\/\/doi.org\/10.1208\/s12248-025-01130-w","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1208\/s12248-025-01160-4","URL":"https:\/\/doi.org\/10.1208\/s12248-025-01160-4","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"145"}}